Serina Therapeutics, Inc.
SER
$2.57
$0.072.80%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.18M | -21.27M | -19.18M | -18.59M | -12.59M |
| Total Depreciation and Amortization | 76.00K | 74.00K | 73.00K | 105.00K | 145.00K |
| Total Amortization of Deferred Charges | 199.00K | 122.00K | 58.00K | 8.00K | 16.00K |
| Total Other Non-Cash Items | 202.00K | 1.35M | -374.00K | -423.00K | -5.29M |
| Change in Net Operating Assets | -437.00K | 1.52M | 1.47M | 2.39M | 2.10M |
| Cash from Operations | -21.14M | -18.20M | -17.96M | -16.51M | -15.62M |
| Capital Expenditure | -66.00K | -84.00K | -59.00K | -64.00K | -54.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -66.00K | -84.00K | -59.00K | -64.00K | -54.00K |
| Total Debt Issued | 4.91M | 4.91M | 4.91M | 5.02M | 118.00K |
| Total Debt Repaid | -- | -- | -- | -1.00K | -9.00K |
| Issuance of Common Stock | 38.19M | 33.62M | 7.56M | 7.08M | 5.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 4.94M | 4.94M | 4.94M | 4.94M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.92M | -4.92M | 0.00 | 4.92M | 4.92M |
| Cash from Financing | 38.18M | 38.55M | 17.41M | 21.96M | 15.60M |
| Foreign Exchange rate Adjustments | 0.00 | -8.00K | -14.00K | -2.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.98M | 20.26M | -616.00K | 5.39M | -73.00K |